FLNA — FILANA THERAPEUTICS, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1069530 ·
Last close
$1.41
Market Cap
$68.11M
52W High
$2.49
52W Low
$1.16
ADV30
427,100
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -11,168,000 | -10,331,000 | 108,367,000 | 86,573,000 | 40,226,000 |
| Dec 2025 | 0 | — | -14,288,000 | -12,539,000 | 118,355,000 | 95,502,000 | 43,952,000 |
| Sep 2025 | 0 | — | -11,860,000 | -10,807,000 | 129,733,000 | 106,080,000 | 48,165,000 |
| Jun 2025 | 0 | — | -45,392,000 | -44,224,000 | 135,384,000 | 112,381,000 | 47,411,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-32,252,000
Investing CF
$-581,000
Financing CF
$-239,000
CapEx
$-575,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.88
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-496,084,000
Inventory
—
Receivables
$120,000
ST Investments
—
EBIT TTM
$-96,126,000
Pretax Income TTM
$-90,973,000
Interest Exp TTM
—
Analysts
1
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -96,126,000 | -90,973,000 | 118,355,000 | 43,952,000 | — | -32,252,000 |
| Dec 2024 | 0 | -142,279,000 | -24,342,000 | 157,533,000 | 11,829,000 | — | -116,929,000 |
| Dec 2023 | 0 | -107,333,000 | -97,217,000 | 151,663,000 | 14,195,000 | — | -82,025,000 |
| Dec 2022 | 0 | -81,482,000 | -76,246,000 | 234,834,000 | 7,295,000 | — | -77,514,000 |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-31,017,000
OpCashFlow TTM
$0
Assets (Latest)
$234,834,000
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RFL | Rafael Holdings, Inc. | $67.62M | $1.32 | — |
| MNOV | MEDICINOVA INC | $67.43M | $1.37 | — |
| IMMP | IMMUTEP Ltd | $66.86M | $0.45 | — |
| LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | $69.96M | $5.65 | — |
| PMVP | PMV Pharmaceuticals, Inc. | $65.60M | $1.23 | — |
News headlines (Yahoo Finance, 1h cache)
Filana Therapeutics Reports Q1 2026 Financial Results and Business Update
2026-05-07 12:00 · Yahoo
Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII
2026-05-05 12:00 · Yahoo
Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data
2026-04-15 12:00 · Yahoo
Filana Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
2026-03-12 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.